STATUTORY RULES
1971 No.
_________
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1970.*
WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1970 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following additional drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1970, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1970.
Dated this twenty ninth day of July, 1971.
Paul Hasluck
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
___________
Amendments of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on the first day of August, 1971.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE Regulation 10.
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits
1. Acetomenaphthone | 8. Almond Oil |
2. Acetomenaphthone Tablets | 9. Aluminium Hydroxide Tablets |
3. Acetrizoic Acid | 10. Amethocaine Hydrochloride |
4. Alcohol Dehydrated | 11. Amitriptyline Injection |
5. Alcohol (95%) | 12. Amodiaquine Tablets |
6. Allopurinol | 13. Amphetamine Sulphate |
7. Aloes | 14. Amphetamine Sulphate Tablets |
* Notified in the Commonwealth Gazette on 1971.
† Statutory Rules 1960, No. 17, as amended to date. For previous amendments of the Public Service Regulations see footnote † to Statutory Rules 1971, No. 44, and see also Statutory Rules 1971, No. 44.
16880/71—Price 30c 10/14.7.1970
First Schedule—continued
15. Amylobarbitone Sodium Tablets | 81. Cholera Vaccine Mixed |
16. Antazoline Hydrochloride | 82. Choline Theophyllinate Tablets |
17. Antazoline Tablets | 83. Cinchocaine Hydrochloride |
18. Antimony Sodium Tartrate | 84. Cinnamon |
19. Antimony Sodium Tartrate Injection | 85. Clofibrate |
20. Apomorphine Hydrochloride | 86. Cochineal |
21. Apomorphine Injection | 87. Colchicine |
22. Arachis Oil | 88. Colchicum Corm |
23. Aspirin Phenacetin and Codeine | 89. Colchicum Liquid Extract |
Tablets | 90. Colchicum Tincture |
24. Aspirin Phenacetin and Codeine | 91. Colistin Tablets |
Tablets Soluble | 92. Colophony |
25. Azathioprine | 93. Concentrated Peppermint Water |
26. Bacillus Calmette-Guérin Vaccine | 94. Coriander |
27. Barium Sulphate | 95. Coriander Oil |
28. Beclomethasone Dipropionate | 96. Corticotrophin |
29. Belladonna Herb | 97. Cottonseed Oil |
30. Belladonna Herb, Powdered | 98. Corticotrophin Injection |
31. Bemegride | 99. Corticotrophin Gelatin Injection |
32. Bendrofluazide | 100. Corticotrophin Zinc Hydroxide Injection |
33. Bemegride Injection | 101. Cresol and Soap Solution |
34. Benzhexol Hydrochloride | 102. Cresol |
35. Benzyl Alcohol | 103. Crotamiton |
36. Betamethasone Sodium Phosphate Tablets | 104. Cyanocobalamin |
37. Bethanidine Sulphate | 105. Cyanocobalamin (57Co) |
38. Bisacodyl | 106. Cyanocobalamin (54Co) |
39. Bisacodyl Suppositories | 107. Cyclamic Acid |
40. Bisacodyl Tablets | 108. Cyclizine Tablets |
41. Botulinum Antitoxin | 109. Cyclobarbitone Calcium |
42. Bupivacaine Hydrochloride | 110. Cyclomethycaine Sulphate |
43. Busulphan | 111. Cyclopenthiazide |
44. Butobarbitone | 112. Cyclopentolate Hydrochloride |
45. Butylated Hydroxyanisole | 113. Cyclopropane |
46. Butylated Hydroxytoluene | 114. Cycloserine |
47. Caffeine Hydrate | 115. Dapsone |
48. Calciferol Solution | 116. Dequalinium Acetate |
49. Calcium Cyclamate | 117. Dequalinium Chloride |
50. Camphor | 118. Desipramine Hydrochloride |
51. Caramiphen Hydrochloride | 119. Dexamphetamine Sulphate |
52. Caramiphen Tablets | 120. Dexamphetamine Tablets |
53. Caraway | 121. Dextran 110 Injection |
54. Carbimazole | 122. Dextromethorphan Hydrobromide |
55. Carbon Dioxide | 123. Dextromethorphan Tablets |
56. Carbromal | 124. Dextropropoxyphene Capsules |
57. Carbromal Tablets | 125. Dextropropoxyphene Hydrochloride |
58. Cardamom Fruit | 126. Dextropropoxyphene Napsylate |
59. Cascara | 127. Dextrose Monohydrate |
60. Catgut, Sterilised, Surgical | 128. Diamorphine Hydrochloride |
61. Cellulose, Oxidised | 129. Diamorphine Injection |
62. Cetylpyridinium Chloride | 130. Diazepam Capsules |
63. Chlorambucil | 131. Dibromopropamidine Isethionate |
64. Chlordiazepoxide Capsules | 132. Dichloralphenazone |
65. Chlordiazepoxide Hydrochloride | 133. Dichlorophen |
66. Chlorhexidine Gluconate Solution | 134. Dichlorphenamide |
67. Chloroform | 135. Diethylcarbamazine Citrate |
68. Chlormadinone Acetate | 136. Diethylcarbamazine Tablets |
69. Chloroquine Phosphate | 137. Digitalis Leaf |
70. Chloroquine Phosphate Injection | 138. Digitalis Prepared |
71. Chloroquine Sulphate | 139. Digitoxin |
72. Chlorothiazide | 140. Digitoxin Tablets |
73. Chlorotrianisene | 141. Dihydrocodeine Injection |
74. Chlorotrianisene Capsules | 142. Dihydrocodeine Tablets |
75. Chlorphenesin | 143. Diloxanide Furoate |
76. Chlorproguanil Hydrochloride | 144. Dilute Alcohols |
77. Chlorproguanil Tablets | 145. Dimenhydrinate |
78. Chlorpropamide | 146. Dimenhydrinate Injection |
79. Chlortetracycline Hydrochloride | 147. Dimenhydrinate Tablets |
80. Chlorthalidone | 148. Dimercaprol |
First Schedule—continued
149. Dimethisterone | 214. Hydroflumethiazide |
150. Dimethisterone Tablets | 215. Hydrogen Peroxide Solution, Strong |
151. Diodone Injection | 216. Hydroxocobalamin |
152. Diphtheria and Pertussis Vaccine | 217. Hydroxychloroquine Sulphate |
153. Diphtheria, Tetanus and Poliomyelitis | 218. Hyoscine Injection |
Vaccine | 219. Hyoscine Eye Ointment |
154. Diphtheria, Tetanus, Pertussis and | 220. Hyoscine Tablets |
Poliomyelitis Vaccine | 221. Hyoscyamus |
155. Dipipanone Hydrochloride | 222. Hyoscyamus Dry Extract |
156. Dipipanone Injection | 223. Indigo Carmine |
157. Dodecyl Gallate | 224. Influenza Vaccine |
158. Domiphen Bromide | 225. Industrial Methylated Spirit |
159. Dried Human Albumin | 226. Inulin |
160. Dusting Powder Absorbable | 227. Inulin Injection |
161. Edrophonium Chloride | 228. Iodinated (181I) Human Serum Albumin Injection |
162. Eltor Vaccine | 229. Iodipamide Meglumine Injection |
163. Emetine and Bismuth Iodide | 230. Iodised Oil Fluid Injection |
164. Emetine Hydrochloride | 231. Iopanoic Acid |
165. Erythromycin | 232. Iopanoic Acid Tablets |
166. Ethacrynic Acid | 233. Iophendylate Injection |
167. Ethchlorvynol | 234. Iothalamic Acid |
168. Ether Anaesthetic | 235. Ipecacuanha, Prepared |
169. Ethinyloestradiol | 236. Isocarboxazid |
170. Ethionamide | 237. Isocarboxazid Tablets |
171. Ethisterone | 238. Isoniazid |
172. Ethopropazine Hydrochloride | 239. Isopropyl Alcohol |
173. Ethotoin | 240. Kaolin, Heavy |
174. Ethyl Chloride | 241. Laevulose |
175. Ethyl Oleate | 242. Lemon Peel, Dried |
176. Ethylenediamine Hydrate | 243. Levallorphan Injection |
177. Eucalyptus Oil | 244. Levorphanol Tartrate |
178. Ethynodiol Diacetate | 245. Lignocaine and Adrenaline Injection |
179. Eugenol | 246. Liothyronine Sodium |
180. Ferric Citrate (60Fe) Injection | 247. Liquorice |
181. Ferrous Fumarate | 248. Lithium Carbonate |
182. Ferrous Succinate Tablets | 249. Lithium Carbonate Tablets |
183. Fludrocortisone Acetate | 250. Lucanthone Hydrochloride |
184. Fluoxymesterone | 251. Lucanthone Tablets |
185. Gallamine Triethiodide | 252. Lynoestrenol |
186. Gallamine Injection | 253. Magnesium Stearate |
187. Gamma Benzene Hexachloride | 254. Maize Oil |
188. Gelatin Sponge, Absorbable | 255. Male Fern |
189. Gentian | 256. Male Fern Extract |
190. Gentian Tincture, Compound | 257. Maleic Acid |
191. Ginger | 258. Measles Vaccine (Inactivated) |
192. Gold (193Au) Injection | 259. Measles Vaccine (Live Attenuated) |
193. Halothane | 260. Mecamylamine Hydrochloride |
194. Helium | 261. Mefenamic Acid |
195. Heparin | 262. Mefenamic Acid Capsules |
196. Hexachlorophane | 263. Megestrol Acetate |
197. Hexylresorcinol | 264. Meglumine Iothalamate Injection |
198. Histamine Acid Phosphate | 265. Melarsoprol |
199. Histamine Acid Phosphate Injection | 266. Melarsoprol Injection |
200. Human Albumin | 267. Mepacrine Hydrochloride |
201. Human Blood, Whole | 268. Mephentermine Sulphate |
202. Human Red Blood, Corpuscles , Concentrated | 269. Meprobamate |
203. Human Fibrin Foam | 270. Meprobamate Tablets |
204. Human Fibrinogen | 271. Mepyramine Injection |
205. Human Normal Gamma Globulin Injection | 272. Mepyramine Maleate |
206. Human Plasma, Dried | 273. Mepyramine Tablets |
207. Human Plasma Protein Fraction | 274. Mercaptopurine |
208. Human Plasma Protein Fraction, Dried | 275. Mersalyl Acid |
209. Human Serum, Dried | 276. Mestranol |
210. Human Thrombin | 277. Metaraminol Tartrate |
211. Hydrochlorothiazide | 278. Methadone Hydrochloride |
212. Hydrocortisone Hydrogen Succinate | 279. Methandienone |
213. Hydrocortisone Sodium Succinate | 280. Methicillin Sodium |
| 281. Methohexitone Injection |
| 282. Methoin |
First Schedule—continued
283. Methoserpidine | 352. Phenazocine Tablets | |
284. Methoserpidine Tablets | 353. Phenelzine Sulphate | |
285. Methoxyflurane | 354. Phenelzine Tablets | |
286. Methyl Hydroxybenzoate | 355. Phenindamine Tartrate | |
287. Methylamphetamine Hydrochloride | 356. Phenindione | |
288. Methylamphetamine Injection | 357. Phenmetrazine Hydrochloride | |
289. Methylamphetamine Tablets | 358. Phenmetrazine Tablets | |
290. Methyldopa | 359. Phenolphthalein Tablets | |
291. Methylergometrine Maleate | 360. Phenolsulphonphthalein | |
292. Methylprednisolone Tablets | 361. Phenoxybenzamine Capsules | |
293. Methylthiouracil | 362. Phenoxybenzamine Hydrochloride | |
294. Methylthiouracil Tablets | 363. Phenoxymethylpenicillin | |
295. Methyprylone | 364. Phenoxymethylpenicillin Potassium | |
296. Methyprylone Tablets | 365. Phentolamine Mesylate | |
297. Metronidazole | 366. Phentolamine Injection | |
298. Nalorphine Hydrobromide | 367. Phosphoric Acid | |
299. Nandrolone Decanoate | 368. Phytomenadione Capsules | |
300. Nandrolone Phenylpropionate | 369. Phytomenadione Tablets | |
301. Naphazoline Hydrochloride | 370. Piperazine Citrate | |
302. Nealbarbitone | 371. Piperazine Phosphate Tablets | |
303. Nealbarbitone Tablets | 372. Poldine Methylsulphate | |
304. Neostigmine Bromide | 373. Poldine Tablets | |
305. Nialamide | 374. Poliomyelitis Vaccine (Inactivated) | |
306. Nialamide Tablets | 375. Poliomyelitis Vaccine (Oral) | |
307. Niclosamide | 376. Potassium Bromide | |
308. Nicotinic Acid | 377. Potassium Chloride Injection | |
309. Nicoumalone | 378. Potassium Hydroxide | |
310. Nikethamide | 379. Potassium Nitrate | |
311. Nikethamide Injection | 380. Prednisolone Sodium Phosphate Injection | |
312. Nitrous Oxide | 381. Prednisolone Pivalate Injection | |
313. Norethandrolone | 382. Prednisone Acetate | |
314. Norethandrolone Tablets | 383. Primaquine Phosphate | |
315. Norethisterone | 384. Probenecid | |
316. Norethynodrel | 385. Procainamide Tablets | |
317. Noscapine | 386. Procaine and Adrenaline Injection | |
318. Novobiocin Calcium | 387. Prochlorperazine Maleate | |
319. Novobiocin Sodium | 388. Prochlorperazine Mesylate | |
320. Novobiocin Tablets | 389. Procyclidine Hydrochloride | |
321. Nux Vomica | 390. Progesterone | |
322. Octyl Gallate | 391. Proguanil Hydrochloride | |
323. Oestradiol Benzoate | 392. Promazine Hydrochloride | |
324. Olive Oil | 393. Promazine Injection | |
325. Opium | 394. Promazine Tablets | |
326. Opium, Powdered | 395. Promethazine Theoclate | |
327. Orange Peel, Dried Bitter | 396. Propranolol Hydrochloride | |
328. Orphenadrine Hydrochloride | 397. Propyl Gallate | |
329. Oxygen | 398. Propyliodone | |
330. Oxyphenbutazone | 399. Propyliodone Injection | |
331. Oxyphenbutazone Tablets | 400. Propyliodone Oily Injection | |
332. Oxyphencyclimine Hydrochloride | 401. Propylthiouracil | |
333. Oxytetracycline Tablets | 402. Pyrazinamide | |
334. Oxytocin Tablets | 403. Pyridostigmine Bromide | |
335. Paramethadione | 404. Pyrimethamine | |
336. Paramomycin Capsules | 405. Pyroxylin | |
337. Paramomycin Sulphate | 406. Quillaia | |
338. Pempidine Tartrate | 407. Quinidine Sulphate | |
339. Penicillamine | 408. Quinine Dihydrochloride Injection | |
340. Penicillamine Hydrochloride | 409. Rabies Antiserum | |
341. Pentamidine Isethionate | 410. Rabies Vaccine | |
342. Pentamidine Injection | 411. Sesame Oil | |
343. Pentolinium Tartrate Tablets | 412. Soda Lime | |
344. Peppermint Oil | 413. Sodium Acetate | |
345. Percutaneous Bacillus Calmette-Guérin Vaccine | 414. Sodium Acetrizoate Injection | |
346. Perphenazine | 415. Sodium Antimonylgluconate | |
347. Perphenazine Tablets | 416. Sodium Antimonylgluconate Injection | |
348. Pethidine Tablets | 417. Sodium Aurothiomalate | |
349. Phenacetin | 418. Sodium Bicarbonate Compound Tablets | |
350. Phenazocine Hydrobromide | 419. Sodium Bromide | |
351. Phenazocine Injection |
| |
First Schedule—continued
420. Sodium Calciumedetate | 466. Tetanus Vaccine (Alum Precipitated) |
421. Sodium Chromate (51Cr) Solution | 467. Tetanus Vaccine (Simple Solution) |
422. Sodium Citrate Tablets | 468. Tetrachloroethylene |
423. Sodium Cyclamate | 469. Tetrachloroethylene Capsules |
424. Sodium Diatrizoate | 470. Tetracycline Tablets |
425. Sodium Diatrizoate Injection | 471. Thiomersal |
426. Sodium Fluoride | 472. Thiopentone Sodium |
427. Sodium Fusidate Capsules | 473. Thiopentone Injection |
428. Sodium Hydroxide | 474. Thioridazine Hydrochloride |
429. Sodium Iodide (131I) Injection | 475. Thyroid |
430. Sodium Iodide (125I) Solution | 476. Thyroxine Sodium |
431. Sodium Iodide (131I) Solution | 477. Tolnaftate |
432. Sodium Iodohippurate (131I) Injection | 478. Tolazoline Hydrochloride |
433. Sodium Iothalamate Injection | 479. Tolazoline Tablets |
434. Sodium Lauryl Sulphate | 480. Tolbutamide |
435. Sodium Phosphate (32P) Injection | 481. Tolu Balsam |
436. Sodium Stibogluconate | 482. Tranylcypromine Sulphate |
437. Sodium Stibogluconate Injection | 483. Tranylcypromine Tablets |
438. Solapsone | 484. Triamterene Capsules |
439. Solapsone Tablets | 485. Trichloroethylene |
440. Spironolactone | 486. Tricyclamol Chloride |
441. Staphylococcus Antitoxin | 487. Tricyclamol Tablets |
442. Stibophen | 488. Tryparsamide |
443. Stibophen Injection | 489. Tryparsamide Injection |
444. Stramonium | 490. Tuberculin, Old |
445. Sulphadiazine Sodium | 491. Tuberculin Purified Protein Derivative |
446. Sulphadimethoxine | 492. Tubocurarine Chloride |
447. Sulphadimidine Injection | 493. Tubocurarine Injection |
448. Sulphadimidine Sodium | 494. Turpentine Oil |
449. Sulphamethizole | 495. Typhoid-Paratyphoid A and B |
450. Sulphamethoxydiazine | 496. Typhoid-Paratyphoid A and B and |
451. Sulphamethoxypridazine | Cholera Vaccine |
452. Sulphapyridine | 497. Typhoid-Paratyphoid A and B and |
453. Sulphinpyrazone | Tetanus Vaccine |
454. Sulphobromophthalein Sodium | 498. Typhoid-Paratyphoid A, B and |
455. Sulphomyxin Injection | C Vaccine |
456. Sulphomyxin Sodium | 499. Undecenoic Acid |
457. Sulthiame | 500. Urea |
458. Suramin | 501. Urea Injection |
459. Suramin Injection | 502. Vancomycin Hydrochloride |
460. Suxamethonium Chloride | 503. Vancomycin Injection |
461. Suxamethonium Bromide | 504. Vinyl Ether |
462. Suxamethonium Chloride Injection | 505. Vitamin A Ester Concentrate |
463. Testosterone | 506. Yellow Fever Vaccine |
464. Testosterone Phenylpropionate Injection | 507. Zinc Undecenoate |
465. Tetanus and Pertussis Vaccine | 508. Zinc Undecenoate Ointment |
____________
SECOND SCHEDULE Regulation 10 (3.).
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
1 | Acepifylline....................... | — |
2 | Acetylsulphafurazole................. | — |
3 | Acetylcysteine..................... | — |
4 | Acrylic Resin...................... | — |
5 | Adrenaline Hydrochloride.............. | — |
6 | Albumaid XP...................... | — |
7 | Aluminium Sodium Silicate............. | — |
8 | Amino Acids...................... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
9 | Amphotericin B..................... | Tetracycline, B.P.C. with buffering agent and Amphotericin B |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
10 | Ampicillin.......................... | — |
11 | Ampicillin Trihydrate.................. | — |
12 | Antazoline Sulphate................... | Naphazoline Nitrate with Antazoline Sulphate |
13 | Ascorbic Acid....................... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Vitamin D and Ascorbic Acid |
|
| Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribers List |
|
| Ferrous Sulphate mixture Prescribers List Children’s Section |
14 | Attapulgite......................... | Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite |
15 | Bacitracin.......................... | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
16 | Bacitracin Zinc....................... | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
17 | Belladonna Herb, Prepared............... | Phenobarbitone with Belladonna Herb, Prepared |
18 | Belladonna, Dry Extract................. | Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna |
19 | Betamethasone ...................... | Betamethasone Acetate with Betamethasone |
20 | Betamethasone Acetate................. | Betamethasone with Betamethasone Acetate |
21 | Betamethasone Sodium Phosphate | — |
22 | Betamethasone Phosphate................ | — |
23 | Betamethasone Valerate................. | Clioquinol with Betamethasone Valerate |
24 | Brompheniramine Maleate............... | — |
25 | Calciferol.......................... | — |
26 | Calcium Di-Oxytetracycline.............. | — |
27 | Capsicum Oleoresin................... | Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin |
28 | Carbachol.......................... | Hypromellose 4500 with Carbachol |
29 | Carbinoxamine Maleate................. | — |
30 | Cascara Dry Extract................... | Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract |
31 | Ceratonia B.P.C. 1949.................. | — |
32 | Chloramine, B.P.C.................... | — |
33 | Chloramphenicol..................... | Polymyxin B Sulphate with Chloramphenicol |
|
| Hydrocortisone Acetate with Chloramphenicol |
34 | Chloramphenicol Palmitate, B.P.C. | — |
35 | Chloramphenicol Stearate................ | — |
36 | Chlorhexidine Gluconate................ | — |
37 | Chlorpheniramine Maleate............... | — |
38 | Chlorpromazine Hydrochloride | — |
39 | Choline Theophyllinate................. | Guaiphenesin with Choline Theophyllinate |
40 | Clemizole Tannate.................... | — |
41 | Clioquinol.......................... | Betamethasone Valerate with Clioquinol |
|
| Flumethasone Pivalate with Clioquinol |
42 | Colistin Sulphate..................... | Neomycin Sulphate with Colistin Sulphate |
43 | Cortisone Acetate..................... | — |
44 | Cyclizine Hydrochloride ................ | Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride |
45 | Cymogran.......................... | — |
46 | Cyproheptadine Hydrochloride | — |
47 | Danthron........................... | Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron |
48 | Demecarium Bromide.................. | — |
49 | Demethylchlortetracycline Hydrochloride | Nystatin with Demethylchlortetracycline Hydrochloride. |
50 | Dexamethasone ...................... | Pramycetin Sulphate with Gramicidin and Dexamethasone |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
51 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
52 | Dexchlorpheniramine Maleate | — |
53 | Dextrans........................... | Dextrose with Dextrans |
|
| Sodium Chloride with Dextrans |
54 | Diazepam.......................... | — |
55 | Dichloralphenazone.................... | — |
56 | Dicyclomine Hydrochloride............... | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
57 | Dienoestrol......................... | — |
58 | Diethanolamine Fusidate................. | — |
59 | Digoxin............................ | — |
60 | Dihydrocodeine Tartrate................. | — |
61 | Dihydrostreptomycin Sulphate, B.P. 1958 | Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
|
| Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
62 | Dihydrotachysterol .................... | — |
63 | Dimethicone, B.P.C.................... | — |
64 | Dioctyl Sodium Sulphosuccinate, B.P.C. | Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. |
|
| Oxyphenisatin Acetate with Dioctyl Sodium Sulphosuccinate B.P.C. |
65 | Diphenhydramine Hydrochloride | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
66 | Diphenylpyraline Hydrochloride | — |
67 | Diphtheria Vaccine.................... | Diphthoria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
68 | Doxycycline Hyclate................... | — |
69 | Doxylamine Succinate.................. | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
70 | Ecothiopate Iodide..................... | — |
71 | Ergometrine Maleate................... | Oxytocin with Ergometrine Maleate |
72 | Ergotamine Tartrate.................... | Caffeine with Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
73 | Erythromycin Estolate.................. | — |
74 | Erythromycin Stearate.................. | — |
75 | Ethosuximide........................ | — |
76 | Ferric Hydroxide...................... | — |
77 | Ferrous Aminoacetosulphate.............. | — |
78 | Ferrous Succinate..................... | — |
79 | Flumethasone Pivalate.................. | Clioquinol with Flumethasone Pivalate |
80 | Fluphenazine Hydrochloride.............. | — |
81 | Framycetin Sulphate ................... | Light Kaolin with Framycetin Sulphate |
|
| Doxamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate |
82 | Galactomin, Formula No. 17 | — |
83 | Galactomin, Formula No. 19 | — |
84 | Glucose Indicator, Blood................ | — |
85 | Glucose Indicator, Urine................. | — |
86 | Goat’s Milk, Dehydrated................. | — |
87 | Goat’s Milk......................... | — |
88 | Gramicidin.......................... | Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
88—cont. |
| Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
89 | Guaiphenesin, B.P.C................... | Theophylline with Guaiphenesin, B.P.C. |
90 | Hydrocortisone....................... | Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Natamycin with Neomycin Sulphate and Hydrocortisone |
91 | Hydrocortisone Acetate................. | Neomycin Sulphate with Hydrocortisone Acetate |
|
| Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride with Hydrocortisone Acetate |
|
| Chloramphenicol with Hydrocortisone Acetate |
92 | Hyoscine Hydrobromide................ | Hypromellose 4500 with Hyoscine Hydrobromide |
|
| Papaveretum with Hyoscine Hydrobromide |
|
| Pethidine Hydrochloride with Hyoscine Hydrobromide |
|
| Morphine Sulphate with Hyoscine Hydrobromide |
93 | Idoxuridine......................... | — |
94 | Ipecacuanha ........................ | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha |
95 | Isoniazid........................... | Sodium Aminosalicylate with Isoniazid |
96 | Isoprenaline Hydrochloride............... | — |
97 | Kanamycin Sulphate, B.P.C............... | — |
98 | Lauryl Dimethylbenzyl Ammonium Chloride | ‘TERIC’ N8 with Lauryl Dimethylbenzyl Ammonium Chloride |
99 | Levallorphan Tartrate .................. | Pethidine Hydrochloride with Levallorphan Tartrate |
100 | Lignocaine Hydrochloride ............... | Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride |
101 | Lincomycin Hydrochloride .............. | — |
102 | Lofenalac.......................... | — |
103 | Lypressin.......................... | — |
104 | Magnesium Aluminium Hydroxide | — |
105 | Magnesium Chloride................... | Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride |
|
| Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride |
106 | Magnesium Hydroxide, B.P.C. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
|
| Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
107 | Mebhydrolin Napadisylate, B.P.C. | — |
108 | Meclastine Hydrogen Fumarate | — |
109 | Meclozine Hydrochloride................ | Ergotamine Tartrate with Caffeine and Meclizine Hydrochloride |
110 | Meglumine......................... | Theophylline with Meglumine |
111 | Methacycline........................ | — |
112 | Methdilazine Hydrochloride .............. | — |
113 | Methenamine Mandelate ................ | — |
114 | Minafen........................... | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
115 | Morphine Tartrate..................... | Morphine Tartrate with Tacrine |
116 | Nalidixic Acid, B.P.C.................. | — |
117 | Naphazoline Nitrate.................... | Naphazoline Nitrate with Antazoline Sulphate |
118 | Natamycin.......................... | Neomycin Sulphate with Hydrocortisone and Natamycin |
119 | Neomycin Sulphate ................... | Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Kaolin with Neomycin Sulphate |
|
| Polymyxin 13 Sulphate with Gramicidin and Neomycin-Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
|
| Prednisolone Sodium Phosphate with Neomycin Sulphate |
|
| Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
120 | Neomycin Undecenoate................. | Bacitracin Zinc with Neomycin Undecenoate |
121 | Neostigmine Methylsulphate.............. | — |
122 | Nicotinamide........................ | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
123 | Nitrofurantoin ....................... | — |
124 | Noradrenaline Acid Tartrate .............. | — |
125 | Nortriptyline Hydrochloride.............. | — |
126 | Nystatin........................... | Tetracycline, B.P.C. with a buffering agent and Nystatin |
|
| Demethylchlortetracycline with Nystatin |
|
| Tetracycline Hydrochloride with Nystatin |
|
| Gramicidin with Neomycin Sulphate |
|
| Triamcinolone Acetonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
127 | Nutramigen......................... | — |
128 | Octatropine Methylbromide.............. | — |
129 | Orciprenaline Sulphate ................. | — |
130 | Oxytetracycline Dihydrate............... | Nystatin with Oxytetracycline Dihydrate |
131 | Oxytetracycline Hydrochloride | Polymyxin B Sulphate with Oxytetracycline Hydrochloride |
|
| Hydrocortisone Acetate with Oxytetracycline Hydrochloride |
132 | Oxyphenisatin Acetate.................. | Dioctyl Sodium Sulphosuccinate, B.P.C. with Oxyphenisatin Acetate |
133 | Oxethazaine......................... | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
134 | Oxytocin........................... | Ergometrine Maleate with Oxytocin |
135 | Pancreatin.......................... | — |
136 | Pancreatin Enzyme, 4 times U.S.N.F. XII strength | — |
137 | Papaveretum, B.P.C................... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
138 | Penicillin, Benethamine, B.P.C............. | Procaine Penicillin with Benethamine Penicillin, B.P.C, and Sodium Penicillin |
139 | Penicillin, Benzathine.................. | Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin |
140 | Penicillin, Benzyl..................... | Procaine Penicillin with Benzyl Penicillin |
141 | Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt) | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
142 | Penicillin, Potassium.................... | Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin |
143 | Penicillin, Procaine..................... | Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin |
|
| Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin |
|
| Benzyl Penicillin with Procaine Penicillin |
144 | Penicillin, Sodium..................... | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
145 | Pentobarbitone........................ | Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone |
146 | Pericyazine.......................... | — |
147 | Pertussis Vaccine...................... | Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
148 | Pethidine Hydrochloride................. | Levallorphan Tartrate with Pethidine Hydrochloride Hyoscine Hydrobromide with Pethidine Hydrochloride |
149 | Phenethicillin Potassium................. | — |
150 | Pheniramine Maleate................... | — |
151 | Phenytoin, B.P.C...................... | — |
152 | Pholcodine.......................... | — |
153 | Pipenzolate Methobromide................ | — |
154 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
155 | Plasma Substitute (Polypeptide) | — |
156 | Polyisobutylene....................... | — |
157 | Polymyxin B Sulphate................... | Chloramphenicol with Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin B Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate |
158 | Polyvinyl Alcohol..................... | Pilocarpine Nitrate and Polyvinyl Alcohol |
159 | Prednisolone......................... | — |
160 | Prednisolone Acetate................... | — |
161 | Methylprednisolone.................... | — |
162 | Prednisolone Sodium Hemisulphate | Sulphaethidole with Prednisolone Sodium Hemisulphate |
163 | Prednisolone Sodium Phosphate | Neomycin Sulphate with Prednisolone Sodium Phosphate |
164 | Prednisolone Pivalate................... | — |
165 | Primidone........................... | — |
166 | Promethazine Hydrochloride.............. | — |
167 | Pseudoephedrine Hydrochloride | — |
168 | Pyrantel Embonate..................... | — |
169 | Pyridoxine Hydrochloride................ | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
170 | Prosobee........................... | — |
171 | Riboflavine.......................... | Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine |
173 | Salbutamol.......................... | — |
173 | Senna Fruit.......................... | — |
174 | Silver Nitrate, Toughened................ | — |
175 | Similac Isomil........................ | — |
176 | Sobee.............................. | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
177 | Sodium Acid Citrate.................... | — |
178 | Sodium Lactate....................... | Potassium Chloride with Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Dextrose and Sodium Lactate Sodium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Sodium Lactate |
179 | Sodium Potassium Tartrate, B.P.C. | Compound Effervescent Powder, B.P.C. |
180 | Sodium Tauroglycocholate, B.P.C. 1954 | Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954 |
181 | Sorbitol............................ | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
182 | Soyalac | — |
183 | Strychnine, B.P.C. 1959................. | Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959 |
184 | Sulphacetamide, B.P.C.................. | Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphacetamide, B.P.C. |
185 | Sulphaethidole....................... | Prednisolone Sodium Hemisulphate with Sulphaethidole |
186 | Sulphafurazole....................... | — |
187 | Sulphamethizole...................... | — |
188 | Sulphamethoxazole.................... | Trimethoprim with Sulphamethoxazole |
189 | Sulphamerazine, B.P. 1958............... | Sulphadiazine with Sulphathiazole, B.P.C. and Sulphamerazine, B.P. 1958 |
|
| Sulphadiazine with Sulphacetamide, B.P.C. and Sulphamerazine, B.P. 1958 |
|
| Sulphadiazine with Sulphadimidine and Sulphamerazine B.P. 1958 |
190 | Sulphaphenazole, B.P.C................. | — |
191 | Sulphathiazole, B.P.C................... | Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphathiazole, B.P.C. |
192 | Surgical Cement...................... | — |
193 | Surgical Cement Solvent................. | — |
194 | Tacrine............................ | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
195 | ‘TERIC’ N8......................... | Lauryl Dimethylbenzyl Ammonium Chloride with ‘TERIC’ N8 |
196 | Testosterone Decanoate................. | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
197 | Testosterone Isocaproate................. | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
198 | Testosterone Phenylpropionate | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone. Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
199 | Testosterone Propionate................. | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
200 | Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
| Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) | |
201 | Tetracycline, B.P.C.................... | Tetracycline, B.P.C. with a buffering agent |
|
| Tetracycline, B.P.C. with a buffering agent and Amphotericin B |
|
| Tetracycline, B.P.C. with a buffering agent and Nystatin |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
202 | Tetracycline Hydrochloride.............. | Tetracycline Hydrochloride with Nystatin Procaine Hydrochloride with Tetracycline Hydrochloride |
203 | Thiamine Hydrochloride................ | Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride |
204 | Thioridazine........................ | — |
205 | Thiotepa........................... | — |
206 | Thonzonium Bromide.................. | Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide |
207 | Thonzylamine Hydrochloride | Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride |
208 | Tiemonium Iodide.................... | — |
209 | Tragacanth, Indian (Gum Karaya) | — |
210 | Triamcinolone Acetonide................ | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
211 | Triclofos Sodium..................... | — |
212 | Trifluoperazine Hydrochloride | — |
213 | Triglyde........................... | — |
214 | Trimeprazine Tartrate, B.P.C. | — |
215 | Trimethoprim....................... | Trimethoprim with Sulphamethoxazole |
216 | Triprolidine Hydrochloride .............. | — |
217 | Vinyl Acetate....................... | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine |
218 | Vinyl Pyrrolidone..................... | Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine |
219 | Viprynium Embonate.................. | — |
220 | Vitamin A.......................... | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A |
221 | Vitamin D.......................... | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D |
___________
THIRD SCHEDULE Regulation 11.
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1. Acepifylline | 20. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex |
2. Acetazolamide Sodium | 21. Aluminium Sodium Silicate |
3. Acetohexamide | 22. Amantadine Hydrochloride |
4. Acetylcholine Chloride | 23. Amaranth Solution, A.P.F. |
5. Acetylcysteine | 24. Amaranth Solution, Compound, |
6. Acetyl Sulphafurazole | A.P.F. |
7. Acidified Golden Syrup, A.P.F. 1955 | 25. Amaranth Solution, B.P.C. |
8. Acriflavine, B.P.C. 1963 | 26. Ambenonium Chloride |
9. Acrylic Resin | 27. Amino Acids |
10. Adrenaline Hydrochloride | 28. Aminocaproic Acid |
11. Adrenaline Mucate | 29. Aminosalicylic Acid |
12. Albumaid XP | 30. Amitriptyline Embonate |
13. Aldosterone | 31. Ammonia Aromatic Spirit, B.P.C. |
14. Aloin, B.P.C. | 32. Ammonia Solution, strong, B.P.C. |
15. Almond Oil Volatile Bitter, B.P.C. 1959 | 33. Ammonium Acetate Solution, strong, |
16. Aloxiprin | B.P.C. |
17. Alprenolol Hydrochloride | 34. Ammonium Bicarbonate, B.P.C. |
18. Aluminium Acetate Solution, B.P.C. | 35. Amphotericin B |
19. Aluminium Hydroxide Mixture, A.P.F. | 36. Angiotensin Amide |
Third Schedule—continued
37. Antazoline Mesylate, B.P.C. | 101. Dexamethasone Metasulphobenzoate |
38. Antazoline Sulphate | 102. Dexamethasone Sodium Phosphate |
39. Anti-Haemophilic Factor of Animal Origin | 103. Dexchlorpheniramine Maleate |
40. Attapulgite | 104. Dextrans |
41. Bacitracin Zinc | 105. Dextriferron |
42. Belladonna Suppository, B.P. 1948 | 106. Dibenzepin Hydrochloride |
43. Benzalkonium Chloride | 107. Diethanolamine Fusidate, B.P.C. |
44. Benzoin Compound Tincture, B.P.C. | 108. Diethazine Hydrochloride, B.P. 1963 |
45. Bephenium Hydroxynaphthoate, B.P.C. | 109. Dihydroergotamine Mesylate |
46. Betahistine Hydrochloride | 110. Dihydroergotoxine Mesylate |
47. Betamethasone Acetate | 111. Dihydrostreptomycin Sulphate, B.P. 1958 |
48. Betamethasone Phosphate | 112. Dimethicone, B.P.C. |
49. Black Snake Antivenene | 113. Dimethindene Maleate |
50. Biperiden Hydrochloride | 114. Dioctyl Sodium Sulphosuccinate, B.P.C. |
51. Bismuth Subgallate, B.P.C. | 115. Diphenylpyraline Hydrochloride |
52. Brompheniramine Maleate | 116. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted |
53. Brown Snake Antivenene | 117. Diphtheria and Tetanus Vaccine, Adult |
54. Buchu Concentrated Infusion, B.P.C. 1954 | 118. Disodium Cromoglycate |
55. Cade Oil, B.P.C. | 119. Doxycycline Hyclate |
56. Caffeine and Sodium Benzoate, B.P.C. 1954 | 120. Doxylamine Succinate |
57. Caffeine Citrate, B.P.C. 1959 | 121. Droperidol |
58. Calcium Di-Oxytetracycline | 122. Ephedrine, B.P.C. |
59. Calcium Gluconogalactogluconate | 123. Erythrityl Tetranitrate |
60. Capreomycin Sulphate | 124. Erythromycin Ethyl Succinate |
61. Capsicum Ointment, B.P.C. | 125. Erythromycin Glucoheptonate |
62. Capsicum Oleoresin | 126. Erythromycin Lactobionate |
63. Carbamazepine | 127. Ethanolamine Oleate |
64. Carbenoxolone Sodium | 128. Ethoxzolamide |
65. Carbinoxamine Maleate | 129. Ethylidene Dicoumarin |
66. Cardamom Aromatic Tincture, B.P.C. | 130. Ethylnoradrenaline Hydrochloride |
67. Catechu Tincture, B.P.C. | 131. Ethyloestrenol |
68. Cephalothin Sodium | 132. Ferric Hydroxide |
69. Ceratonia B.P.C. 1949 | 133. Ferrous Aminoacetosulphate |
70. Cetomacrogol Emulsifying Wax, B.P.C. | 134. Ferrous Phosphate Compound, Syrup B.P.C. |
71. Charcoal | 135. Flumethasone Pivalate |
72. Chloramine, B.P.C. | 136. Fluorouracil Sodium |
73. Chloramphenicol Palmitate, B.P.C. | 137. Fluphenazine Enanthate |
74. Chloramphenicol Stearate | 138. Flurandrenolone Acetonide |
75. Chloramphenicol Succinate | 139. Framycetin Sulphate |
76. Chlorhexidine Acetate | 140. Galactomin, Formula No. 17 |
77. Chlorhexidine Gluconate | 141. Galactomin, Formula No. 19 |
78. Cholestyramine | 142. Gall and Opium Ointment, B.P.C. 1963 |
79. Clemizole Hydrochloride | 143. Gelsemium Tincture, B.P.C. |
80. Clemizole Tannate | 144. Gentamicin Sulphate |
81. Clopamide | 145. Ginger Syrup, B.P.C. |
82. Clorexolone | 146. Glibenclamide |
83. Coal Tar, B.P.C. | 147. Glucagon Hydrochloride |
84. Coal Tar Solution Strong, B.P.C. | 148. Glucose Indicator-Blood |
85. Cochineal Tincture, B.P. 1948 | 149. Glucose Indicator-Urine |
86. Coconut Oil, B.P.C. 1949 | 150. Glycerophosphate Compound Syrup, A.P.F. |
87. Colophony Ointment, B.P.C. 1959 | 151. Glycopyrronium Bromide |
88. Copper Sulphate, B.P.C. | 152. Glymidine |
89. Creosote, B.P.C. 1959 | 153. Goat’s Milk, Dehydrated |
90. Cyclothiazide | 154. Goat’s Milk, Whole (Sterilised) |
91. Cycrimine Hydrochloride | 155. Gramicidin |
92. Cymogran | 156. Guaiphenesin, B.P.C. |
93. Cytosine Arabinoside Hydrochloride | 157. Hamamelis Liquid Extract, B.P.C. |
94. Danthron | 158. Hexocyclium Methylsulphate |
95. Death Adder Antivenene | 159. Haemodialysis Fluid—Concentrate |
96. Debrisoquine | 160. Hydrargaphen |
97. Demecarium Bromide | 161. Hydromorphone Hydrochloride |
98. Deoxycortone Pivalate, B.P. 1963 | 162. Hydroxyprogesterone |
99. Desferrioxamine Mesylate |
|
100. Deslanoside |
|
Third Schedule—continued
163. Hyoscine Butylbromide | 219. Methsuximide |
164. Hyoscine Methobromide | 220. Methyclothiazide |
165. Hypophosphorous Acid, Dilute, | 221. Methylphenobarbitone, B.P.C. 1963 |
B.P.C. 1963 | 222. Methylprednisolone Acetate |
166. Hypromellose 4500 | 223. Methylprednisolone Sodium Succinate |
167. Indomethacin | 224. Methysergide Maleate |
168. Influenza Vaccine—Sub Unit type | 225. Metyrapone |
(Desoxycholate Treated) | 226. Minafen |
169. Injection of Amino Acid with | 227. Minocycline Hydrochloride |
Sorbitol and Alcohol | 228. Morphine Tartrate |
170. Injection of Casein Hydrolysate with | 229. Myrrh Tincture, B.P.C. |
Laevulose and Alcohol | 230. Nalidixic Acid, B.P.C. |
171. Injection of Dextran with Dextrose | 231. Nandrolone Hexoxyphenyl Propionate |
172. Injection of Potassium Chloride with Sodium Lactate and Dextrose | 232. Natamycin |
173. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose | 233. Neomycin Undecenoate |
174. Injection of Sodium Chloride with Sodium Lactate and Dextrose | 234. Nitrazepam |
175. Insect Allergen Extract—Honey Bee | 235. Nitromin |
176. Insect Allergen Extract—Jumper Ant | 236. Nutramigen |
177. Insect Allergen Extract—Paper Wasp | 237. Octatropine Methylbromide |
178. Insulin Injection, specially purified | 238. Oestradiol Dipropionate, B.P.C. 1954 |
179. Insulin Isophane Injection, specially purified | 239. Oestrone, B.P.C. 1954 |
180. Insulin Injection, Special P (Pig) | 240. Oily Opthalmic Vehicle, A.P.F. 1955 |
181. Invert Sugar | 241. Orange Syrup, B.P.C. |
182. Iron Polymaltose Complex | 242. Orange Tincture, B.P.C. |
183. Isoprenaline Hydrochloride | 243. Oxethazaine |
184. Isopropamide Iodide | 244. Oxprenolol Hydrochloride |
185. Kanamycin Sulphate, B.P.C. | 245. Oxycodone Pectinate |
186. Lanatoside-C | 246. Oxymel, B.P.C. |
187. Lauryl Dimethyl Benzyl Ammonium Chloride | 247. Oxymel of Squill, B.P.C. |
188. Lavender Spike Oil, B.P.C. | 248. Oxymetholone |
189. Lead Subacetate Dilute Solution | 249. Oxyphenisatin Acetate |
190. Lead Subacetate Strong Solution B.P.C. | 250. Oxyphenonium Bromide |
191. Levodopa | 251. Oxytetracycline |
192. Lemon Oil Terpeneless, B.P.C. | 252. Oxytocin |
193. Lemon Tincture, B.P. 1958 | 253. Pancreatin Enzyme, U.S.N.F. XII |
194. Leucovorin | 254. Papaveretum, B.P.C. |
195. Lincomycin Hydrochloride | 255. Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955 |
196. Lipopancreatin | 256. Paraben Ophthalmic Vehicle, A.P.F. 1955 |
197. Lobelia Ethereal Tincture, B.P.C. | 257. Paraffin Liquid Light, B.P.C. 1963 |
198. Lofenalac | 258. Paramethasone Acetate |
199. Lypressin | 259. Pectin |
200. Magenta, B.P.C. | 260. Penicillinase |
201. Magnesium-Aluminium Hydroxide | 261. Penicillin Benethamine, B.P.C. |
202. Magnesium Hydroxide, B.P.C. | 262. Pentaerythritol Tetranitrate, diluted, B.P.C. |
203. Maphenide Acetate | 263. Pentazocine Lactate |
204. Mebeverine Hydrochloride | 264. Penthienate Methobromide |
205. Mebhydrolin Napadisylate, B.P.C. | 265. Pentobarbitone |
206. Meclastine Hydrogen Fumarate | 266. Pericyazine |
207. Medroxyprogesterone Acetate | 267. Pericyazine Mesylate |
208. Melphalan | 268. Peritoneal Dialysis Solution with Dextrose |
209. Mepenzolate Bromide | 269. Phenformin Hydrochloride |
210. Mercaptomerin Sodium | 270. Pheniramine Maleate |
211. Mercuric Chloride, B.P.C. | 271. Pheniramine Para-Aminosalicylate |
212. Metaraminol Bitartrate | 272. Phenol Ointment, B.P. 1948 |
213. Methacycline | 273. Phenoxymethylpenicillin, Benzathine |
214. Methaqualone Hydrochloride | 274. Phenoxymethylpenicillin, Hydrabamine |
215. Methdilazine Hydrochloride | 275. Phensuximide, B.P.C. |
216. Methenamine Mandelate | 276. Phenthimentonium |
217. Methenolone Acetate | 277. Phenytoin, B.P.C. |
218. Methoxamine Hydrochloride, B.P.C. | 278. Phthalylsulphacetamide |
| 279. Physostigmine, B.P.C. |
| 280. Pilocarpine Hydrochloride |
| 281. Pipenzolate Methobromide |
Third Schedule—continued
282. Pituitary Hormone, Follicle-stimulating, Human | 338. Stearic Acid, B.P.C. |
283. Pituitary Hormone, Growth, Human | 339. Stilboestrol Diphosphate |
284. Pituitary (Posterior Lobe) Powdered, B.P.C. | 340. Stone Fish Antivenene |
285. Plasma Substitute (Polypeptide) | 341. Streptokinase |
286. Polyisobutylene | 342. Strychnine, B.P.C. 1959 |
287. Polyoestradiol Phosphate | 343. Sulphacetamide, B.P.C. |
288. Polyvinyl Alcohol | 344. Sulphaethidole |
289. Potassium Chlorate, B.P.C. | 345. Sulphamerazine B.P. 1958 |
290. Potassium Effervescent Tablets | 346. Sulfamethoxazole |
291. Potassium Perchlorate | 347. Sulphaphenazole, B.P.C. |
292. Practolol | 348. Sulphasalazine |
293. Prednisolone Acetate | 349. Sulphasymazine |
294. Prednisolone Sodium Succinate | 350. Sulphathiazole, B.P.C. |
295. Prednisolone Sodium Hemisulphate | 351. Sulphurated Potash, B.P.C. |
296. Prednisolone Tertiary Butyl Acetate | 352. Sulphur Sublimed, B.P.C. |
297. Procarbazine Hydrochloride | 353. Surgical Cement |
298. Prochlorperazine | 354. Surgical Cement Solvent |
299. Proscillaridin | 355. Tacrine |
300. Prosobee | 336. Taipan Antivenene |
301. Protriptyline Hydrochloride | 357; Tartrazine, B.P.C. 1954 |
302. Pseudoephedrine Hydrochloride | 358. ‘TERIC’ N8 |
303. Pumilio Pine Oil, B.P.C. | 359. Testosterone Decanoate |
304. Pyrantel Embonate | 360. Testosterone Enanthate |
305. Pyridine Aldoxime Methiodide | 361. Testosterone Isocaproate |
306. Quillaia Tineture, B.P.C. | 362. Tetracosactrin |
307. Quinethazone | 363. Tetracycline, B.P.C. |
308. Quinidine Bisulphate | 364. Thiabendazole |
309. Raspberry Syrup, B.P.C. | 365. Thiethylperazine Malate |
310. Rauwolfia Alkaloids | 366. Thiethylperazine Maleate |
311. Rauwolfia Serpentina, B.P.C. | 367. Thioridazine |
312. Red Back Spider Antivenene | 368. Thonzonium Bromide |
313. Rolitetracycline | 369. Thonzylamine Hydrochloride |
314. Rosemary Oil, B.P.C. | 370. Thyrotrophin |
315. Salbutamol | 371. Tiemonium Iodide |
316. Salicylamide | 372. Tiger Snake Antivenene |
317. Secbutobarbitone Sodium | 373. Titanium Dioxide, B.P.C. |
318. Senega, Concentrated Infusion, B.P.C. 1968 | 374. Tolazamide |
319. Senna Fruit Extract (Standardised) | 375. Tragacanth, Indian (Gum Karaya) |
320. Siberian Fir Oil, B.P.C. 1949 | 376. Tragacanth Mucilage |
321. Silver Protein, B.P.C. | 377. Tretamine |
322. Silver Protein Mild, B.P.C. | 378. Tridihexethyl Chloride. |
323. Similac Isomil | 379. Triethanolamine, B.P.C. |
324. Snake Bite Antivenene—Polyvalent | 380. Triglyde |
325. Sobee | 381. Trimeprazine Tartrate, B.P.C. |
326. Sodium Folate | 382. Trimethoprim |
327. Sodium Lactate | 383. Trimipramine Maleate |
328. Sodium Lactate Compound Injection, B.P. with Dextrose | 384. Trimipramine Mesylate |
329. Sodium Nitroprusside | 385. Trolnitrate Phosphate |
330. Sodium Potassium Tartrate, B.P.C. | 386. Typhoid Vaccine |
331. Sodium Tauroglycocholate, B.P.C. 1954 | 387. Typhoid and Cholera El Tor Combined Vaccine |
332. Sorbide Nitrate | 388. Vanillin |
333. Sorbitol | 389. Vasopressin Tannate |
334. Soyalac | 390. Vinblastine Sulphate |
335. Squill Tincture, B.P.C. | 391. Vincristine Sulphate |
336. Stanolone | 392. Vinyl Acetate |
337. Stanozolol | 393. Vinyl Pyrrolidone |
| 394. Vitamin A |
| 395. Vitamin D |
| 396. Zinc Gelatin, B.P.C. |
FOURTH SCHEDULE Regulation 12.
Additives
1. Acetone B.P.C. | 15. Ether Anaesthetic B.P. |
2. Alcohol (95%) B.P. | 16. Eucalyptol B.P.C. |
3. Arachis Oil B.P. | 17. Eucalyptus Oil B.P. |
4. Amethocaine Hydrochloride B.P. | 18. Honey—Purified B.P.C. |
5. Camphor B.P. | 19. Maize Oil B.P. |
6. Carmine Solution A.P.F. | 20. Olive Oil B.P. |
7. Citronella Oil B.P.C. | 21. Peppermint Oil B.P. |
8. Chlorhexidine Gluconate Solution B.P. | 22. Sodium Thiosulphate B.P.C. |
9. Chloroform B.P. | 23. Solution of Burnt Sugar B.P.C. 1959 |
10. Concentrated Anise Water B.P.C. | 24. Spirit Methylated Industrial B.P. |
11. Concentrated Cinnamon Water B.P.C. | 25. Syrup of Pholcodine Citrate B.P.C. 1959 |
12. Concentrated Peppermint Water B.P. | 26. Turpentine Oil B.P. |
13. Dextrose Monohydrate B.P. | 27. Xylene B.P.C. 1949 |
14. Dilute Alcohols B.P. |
|
__________
FIFTH SCHEDULE Regulation 14.
Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
1 | Acetylcysteine............................ | Cystic Fibrosis (mucoviscidosis) |
2 | (1) Aspirin with Paracetamol and Caffeine Tablets | Any disease or condition in a pensioner |
| (2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets |
|
3 | Acrylic Resin............................. | Ileostomy or colostomy conditions |
4 | Albumaid XP............................. | With the written authority of the Director-General, Phenylketonuria |
5 | Aldosterone............................... | With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison’s disease and salt-losing congenital adrenal hypoplasia) |
6 | Alprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis Right ventricular outflow tract obstruction Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
7 | Alprenolol Hydrochloride Tablets | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis Right ventricular outflow tract obstruction Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
8 | Amantadine Hydrochloride................ | With the written authority of the Director-General, treatment of Parkinson’s disease in conjunction with Levodopa |
9 | Ambenonium Chloride................... | Myasthenia gravis |
10 | Aminocaproic Acid..................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
11 | Aminosalicylic Acid.................... | Tuberculosis |
12 | Amphotericin B Injection................. | Systemic mycoses |
13 | (1) Ampicillin Capsules, B.P............... | Infections by susceptible organisms when these cannot be safely and effectively treated with sulphonamides, phenoxymethyl penicillin or phenethicillin |
| (2) Ampicillin Injections, Tablets and Suspensions | |
|
| Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin or where the patient is sensitive to sulphonamides |
|
| Broad spectrum antibiotic treatment of patients undergoing steroid therapy or recently subjected to steroid therapy |
|
| Bacterial endocarditis |
|
| Meningitis |
14 | Ascorbic Acid Tablets, B.P................ | Any disease or condition in a pensioner |
15 | Azathioprine......................... | With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital |
16 | Benzathine Penicillin, B.P................ | Prophylaxis of recurrent streptococcal infections (including rheumatic fever) |
17 | Benzoin Compound Tincture, B.P.C. aerosol spray | Ileostomy or colostomy conditions |
18 | Benzylpenicillin Injection, 5,000,000 units | Bacterial endocarditis or septicaemia |
19 | (1) Benzylpenicillin Tablets, B.P. | Prophylaxis of recurrent streptococcal infections, (including rheumatic fever) |
| (2) Benzylpenicillin Capsules | |
20 | Benzylpenicillin Injection, 10,000,000 units | Bacterial endocarditis or septicaemia |
| Gastrointestinal surgery | |
21 | (1) Benzylpenicillin with Streptomycin Sulphate | Endocarditis due to streptococcus faccalis or streptococcus viridans |
| (2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate |
|
22 | Betahistine Hydrochloride................ | Meniere’s Syndrome |
23 | Betamethasone Acetate and Betamethasone Injection | Intra-articular use |
| With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy | |
24 | Busulphan Tablets, B.P.................. | Treatment in malignant neoplasia |
25 | (1) Calciferol Tablets, Strong, B.P. | Any disease or condition in a pensioner |
| (2) Calciferol, B.P...................... | With the written authority of the Director-General— |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy |
|
| Vitamin D-resistant rickets |
26 | Calcium Aminosalicylate................. | Tuberculosis |
27 | Capreomycin Sulphate................... | Tuberculosis |
28 | Carbamazepine........................ | Epilepsy |
|
| Trigeminal neuralgia |
29 | Carbenicillin Sodium.................... | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
30 | Carbenoxolone Sodium.................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
31 | Cephaloridine ........................ | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
32 | Cephalothin Sodium.................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
33 | Ceratonia........................... | Oesophageal reflux in infants |
34 | Charcoal Tablets...................... | Ileostomy or colostomy conditions |
35 | Chlorambucil Tablets, B.P................ | Treatment in malignant neoplasia |
36 | Chloramine Deodorant Tablets and | Ileostomy or colostomy conditions |
| Powder |
|
37 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| (2) Chloramphenicol Injections............. | Intraocular infections |
| (3) Chloramphenicol Oral Suspension | Rickettsioses |
| Typhoid | |
|
| The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that Chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
38 | Chlorotrianisene Tablets................. | Carcinoma of the prostate |
39 | (1) Chlorpromazine Hydrochloride B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Chlorpromazine Injection, B.P. | Major psychoses including— |
| (3) Chlorpromazine Tablets, B.P. | Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
40 | Cholestyramine....................... | With the written authority of the Director-General— |
|
| Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Pruritis associated with partial biliary obstruction not responding to other therapy |
|
| Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type II) not responding to other therapy |
|
| A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type II) in patients who respond to treatment with cholestyramine but do not respond to other therapy |
41 | Clofibrate........................... | With the written authority of the Director-General— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report |
42 | (1) Cloxacillin Sodium, B.P............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Capsules, B.P. | |
|
| With the written authority of the Director-General, life threatening infection where bacteriological evidence confirms the presence of penicillinase-producing staphylococci |
43 | (1) Codeine Phosphate with Aspirin Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin Tablets |
|
| (3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets |
|
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act |
43—cont. | (4) Codeine Phosphate with Aspirin and Paracetamol Tablets |
|
| (5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets |
|
44 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyaneus infection, other gram-negative infections where no other drug is effective |
45 | Cyanocobalamin Injection, B.P............. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
46 | (1) Cycloserine Tablets, B.P............... | Tuberculosis |
| (2) Cycloserine Capsules, B.P. |
|
47 | Cymogran........................... | With the written authority of the Director-General, phenylketonuria |
48 | (1) Cyproheptadine Hydrochloride, B.P. | Allergic rhinitis |
| Allergic dermatoses | |
| (2) Cyproheptadine Tablets, B.P. | Migraine |
49 | Cytosine Arabinoside Hydrochloride | Any disease or condition in a patient receiving treatment in or at an approved hospital |
50 | Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and ‘TERIC’ N8) | Ileostomy or colostomy conditions |
51 | (1) Deoxycortone Acetate Injection, B.P. | Adrenal cortical hypofunction including Addison’s disease |
| (2) Deoxycortone Pivalate Injection, B.P. | Total adrenalectomy |
| (3) Deoxycortone Acetate Implants, B.P. |
|
| (4) Deoxycortone Acetate Tablets |
|
52 | Desferrioxamine Mesylate | Acute iron poisoning |
|
| Hepatolenticular degeneration |
53 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
54 | (1) Diazepam, B.P...................... | Any disease or condition in a pensioner |
| (2) Diazepam Tablets, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a patient discharged from an approved hospital at which he received treatment for a mental disorder |
|
| Epilepsy |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Motor neurone lesion |
|
| Multiple sclerosis |
|
| Radiation sickness |
|
| Stiff-man syndrome |
55 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
56 | Dienoestrol Cream..................... | Any disease or condition in a pensioner |
57 | (1) Dihydroergotoxine Mesylate Tablets | For the treatment of patients who have suffered an attack of paralytic poliomyelitis |
| (2) Dihydroergotoxine Mesylate Injection |
|
58 | Dihydrotachysterol | Hypoparathyroidism |
59 | Dimethicone Aerosol Spray............... | Ileostomy or colostomy conditions |
60 | Dimethicone Creams.................... | Use with surgical appliances |
61 | (1) Dioctyl Sodium Sulphosuccinate with Danthron | Any disease or condition in a pensioner |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
61—cont. | (2) Dioctyl Sodium Sulphosuccinate with Oxyphenisatin Acetate |
|
62 | Disodium Cromoglycate.................. | With the written authority of the Director-General— |
|
| The prevention of attacks of asthma in the case of a patient whose attacks of asthma have been sufficiently severe and frequent to interfere seriously with his normal activities of life and whose recurrences of asthma— |
|
| (a) were not controlled by adequate use of bronchodilators and other recognized methods of prevention and treatment; or |
|
| (b) required the continuous use of corticosteroid therapy |
63 | Droperidol........................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
64 | Ethacrynic Acid....................... | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
65 | Ethinyloestradiol Tablets, B.P............... | Any disease or condition in a pensioner |
|
| Carcinoma of the breast post-menopausal |
|
| Carcinoma of the prostate |
|
| Hereditary telangiectasis |
|
| Premature menopause that is surgically induced |
|
| Turner’s syndrome |
66 | Ethionamide......................... | Tuberculosis |
67 | Ethisterone Tablets, B.P.................. | Turner’s syndrome |
68 | Ethyloestrenol........................ | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Osteomalacia following gastrectomy |
69 | Fludrocortisone Tablets, B.P............... | Adrenal cortical hypoplasia including Addison’s disease |
|
| Total adrenalectomy |
70 | Fluorouracil Sodium.................... | Treatment in malignant neoplasia |
71 | Fluoxymesterone Tablets, B.P.............. | Eunuchism |
|
| Eunuchoidism |
|
| Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Proven aplastic anaemias |
72 | (1) Fluphenazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Fluphenazine Tablets, B.P.............. | Major psychoses including— |
| (3) Fluphenazine Enanthate | Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
73 | (1) Folic Acid, B.P..................... | Cystic fibrosis |
|
| Proven folic acid deficiency |
| (2) Folic Acid Tablets, B.P. 5 mg. | Sprue or the sprue-like syndrome |
74 | Folic Acid Tablets, B.P. 0.5 mg. | Cystic fibrosis |
|
| Pregnancy |
75 | Framycetin Sulphate Tablets............... | Bowel sterilization preparatory to major surgery |
76 | Frusemide Tablets, B.P.................. | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
77 | Galactomin Formula No. 17............... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years |
78 | Galactomin Formula No. 19............... | With the written authority of the Director-General, glucose-galactose malabsorption |
79 | Gentamicin Sulphate.................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
80 | Glucose Indicator—Blood................ | With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing |
81 | Goat’s Milk, Dehydrated................. | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
82 | Goat’s Milk, Whole (Sterilized)............. | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
83 | (1) Griseofulvin, B P.................... | With the written authority of the Director-General, |
| (2) Griseofulvin Tablets, B.P............... | for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light |
84 | Halibut Liver Oil Capsules................ | Any disease or condition in a pensioner |
85 | Haloperidol.......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
86 | Hydrocortisone Acetate Injection, B.P. | Intra-articular use |
87 | Hydrocortisone Sodium Succinate Injection | Acute adrenal cortical hypofunction due to medical or surgical crisis |
|
| Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subjected to steroid therapy |
88 | Hydroxocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
89 | Hydroxyprogesterone Caproate ............. | Carcinoma of the endometrium |
|
| Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy |
90 | Idoxuridine.......................... | Infections caused by Herpes Simplex Virus |
91 | Influenza Vaccine...................... | For prophylaxis of pensioners only |
92 | Insect Allergen Extract—Honey Bee | With the written authority of the Director-General, service constitutional reaction to bee stings |
93 | Insect Allergen Extract—Jumper Ant | With the written authority of the Director-General, severe constitutional reaction to jumper ant stings |
94 | Insect Allergen Extract—Paper Wasp | With the written authority of the Director-General, severe constitutional reaction to wasp stings |
95 | Isoniazid Tablets, B P................... | Tuberculosis |
96 | Isoprenaline Hydrochloride Tablets, 30 mg. | Stokes-Adams Syndrome |
97 | Kanamycin Sulphate Capsules, Injections and Oral Solution | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic |
98 | Leucovorin.......................... | Antidote to folic acid antagonists |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
99 | Levodopa........................... | With the written authority of the Director-General, treatment of Parkinson’s disease |
100 | Levorphanol Tartrate.................... | Obstetrical use |
|
| Severe intractable pain |
101 | Lignocaine Injection, B.P................. | Cardiac arrhythmias |
102 | Lincomycin Hydrochloride................ | Gram positive coccal infections where those cannot be safely and effectively treated with a penicillin |
|
| Osteomyelitis |
103 | Liothyronine Tablets, B.P................. | Myxoedema |
104 | Lofenalac........................... | With the written authority of the Director-General, phenylketonuria |
105 | Lypressin Nasal Spray................... | Diabetes insipidus |
106 | Maphenide Acetate..................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
107 | Medroxyprogesterone Acetate Tablets, 2 5 mg. | Carcinoma of the endometrium |
108 | Medroxyprogesterone Acetate Tablets, 10 mg. | Carcinoma of the endometrium |
| Precocious puberty | |
109 | Medroxyprogesterone Acetate Tablets, 100 mg. | Carcinoma of the breast |
| Carcinoma of the endometrium | |
|
| Hypernephroma |
110 | Medroxyprogesterone Acetate | Carcinoma of the endometrium |
| Injections | Hypernephroma |
|
| Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
111 | Melphalan........................... | Treatment in malignant neoplasia |
112 | Mercaptopurine Tablets, B.P............... | Allergic granulomatous angiitis |
|
| Lupus erythematosus |
|
| Nephrotic syndrome |
|
| Periarteritis (Nodosa) |
|
| Treatment in malignant neoplasia |
113 | (1) Methandienone Tablets, B P. | With the written authority of the Director-General— |
| (2) Methenolone Acetate | Intermittent use for corticosteroids-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
114 | Methicillin Sodium, B.P. for Injection | Proven or suspected staphylococcal septicaemia |
115 | Methotrexate Tablets.................... | Treatment in malignant neoplasia |
116 | Methotrexate Injections.................. | Treatment in malignant neoplasia |
117 | Methylprednisolone Acetate............... | With the written authority of the Director-General— |
| Retention Enema...................... | Colitis, ulcerative, proven by sigmoidoscopy or radiological report |
|
| Proctitis, proven by sigmoidoscopy |
118 | Methylprednisolone Acetate Injection | Intra-articular use |
119 | (1) Methyltestosterone Tablets, B.P. | Carcinoma of the breast |
| Eunuchism | |
| (2) Methyltestosterone, B.P............... | Eunuchoidism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
120 | Methysergide Maleate................... | Treatment of severe recalcitrant migraine where other treatment has failed |
121 | Metyrapone.......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
122 | Minafen............................ | With the written authority of the Director-General, phenylketonuria |
123 | Minocycline Hydrochloride............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
124 | Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain |
125 | Mustine Hydrochloride Injection | Treatment in malignant neoplasia |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
126 | Nalidixic Acid........................ | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides |
127 | Nandrolone Decanoate.................. | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Severe osteoporosis due to proven pancreatitis |
128 | Nandrolone Hexoxyphenyl Propionate | Carcinoma of the breast |
| With the written authority of the Director-General— | |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
129 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |
130 | Neomycin Sulphate Powder............... | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
131 | Neomycin Tablets, B.P. | Bowel sterilization preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
132 | Nicotinic Acid Tablets, B.P................ | Any disease or condition in a pensioner |
133 | (1) Nitrofurantoin Tablets, B.P............. | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides |
| (2) Nitrofurantoin Oral Suspension | |
134 | Nitromin........................... | Treatment in malignant neoplasia |
135 | Norethisterone Acetate, B.P............... | Carcinoma of the breast |
136 | Norethisterone Tablets, B.P............... | Endometriosis |
|
| Metropathia haemorrhagica |
|
| Precocious puberty |
137 | Nutramigen......................... | With the written authority of the Director-General— |
|
| Cow’s milk allergy in children under the age of four years |
|
| Cystic Fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Lactose intolerance |
138 | Oxprenolol Hydrochloride Tablets | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
139 | Oxprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction Dissecting aneurysm, aortic | |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
139—cont. |
| angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
140 | Oxycodone Pectinate.................... | Treatment in malignant neoplasia |
141 | Oxymetholone........................ | With the written authority of the Director-General— |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
142 | (1) Pancreatin, B.P..................... | Cystic Fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4 X U.S.N.F. XII | Following pancreatico-duodenectomy |
| (3) Pancrelipase | Pancreatic steatorrhoea |
|
|
|
143 | (1) Paracetamol Mixture ................. | Any disease or condition in a pensioner |
| (2) Paracetamol Tablets, B.P. |
|
144 | Paracetamol with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner |
145 | (1) Paraffin Liquid Emulsion.............. | Any disease or condition in a pensioner |
| (2) Paraffin Liquid Emulsion with Phenolphthalein |
|
146 | Penicillamine......................... | With the written authority of the Director-General— |
|
| Acute heavy metal intoxication |
|
| Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson’s disease (hepatolenticular degeneration) |
147 | (1) Pericyazine Mesylate................. | Any disease or condition in a patient receiving treatment in or at an approved hospital; |
| (2) Pericyazine | |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
148 | Phytomenadione Injection, 10 mg. per ml. | Antidote to anticoagulants |
| Haemorrhagic diathesis associated with malabsorption | |
149 | Phytomenadione Injection, B.P., 1 mg. in 1 ml. | Antidote to anticoagulants |
| Suspected cerebral trauma of the new born Haemorrhagic diathesis associated with malabsorption | |
|
| Haemorrhagic disease of the new born |
150 | Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus |
151 | Plasma Substitute (Polypeptide)............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
153 | Polyisobutylene....................... | Ileostomy or colostomy conditions |
152 | Polymyxin B. Sulphate Powder............. | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
154 | Polyoestradiol Phosphate................. | Carcinoma of the breast |
|
| Carcinoma of the prostate |
155 | Practolol Injection..................... | Dissecting aneurysm, aortic |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents. |
156 | Practolol Tablets...................... | With the written authority of the Director-General— |
|
| Dissecting aneurysm, aortic |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
156—cont. |
| Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
157 | Prednisolone Sodium Phosphate Retention Enema find Suppository | With the written authority of the Director-General— |
| Ulcerative colitis proven by sigmoidoscopy or radiological report | |
|
| Proctitis proven by sigmoidoscopy |
158 | (1) Prednisolone Acetate Injection | Intra-articular use |
| (2) Prednisolone Butyl Acetate Injection |
|
159 | Prednisolone Sodium Succinate Injection | Acute adrenal cortical hypofunction due to any medical or surgical crisis |
|
| Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subject to steroid therapy |
160 | Procarbazine Hydrochloride............... | Treatment in malignant neoplasia |
161 | (1) Prochlorperazine.................... | Meniere’s Syndrome |
| (2) Prochlorperazine Tablets, B.P. |
|
162 | Progesterone......................... | Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
163 | Promethazine Theoclate Tablets, B.P. | Vomiting in pregnancy |
164 | Propranolol Injection, B.P. | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
165 | Propranolol Tablets, B.P................. | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whoso attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
166 | Proscillaridin......................... | Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C |
167 | Prosobee............................ | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
168 | Pyrazinamide | Any disease or condition in a patient receiving treatment in or at an approved hospital |
169 | (1) Pyridostigmine Injection, B.P. | Myasthenia gravis |
| (2) Pyridostigmine Tablets, B.P. |
|
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
170 | Pyridoxine Hydrochloride Tablets | Homocystinuria |
|
| Radiation sickness |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
|
| Sideroblastic (refractory anaemia) |
|
| Proven pyridoxine responsive anaemia |
|
| With the written authority of the Director-General, primary hyperoxaluria |
171 | Riboflavine Tablets..................... | Any disease or condition in a pensioner |
172 | Senna Fruit Extract (standardised) | Any disease or condition in a pensioner |
173 | Similac Isomil........................ | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
174 | Sobee | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
175 | (1) Sodium Aminosalicylate Tablets, B.P. | Tuberculosis |
| (2) Sodium Aminosalicylate Injection |
|
| (3) Sodium Aminosalicylate Cachets |
|
| (4) Sodium Aminosalicylate Granules |
|
| (5) Sodium Aminosalicylate with |
|
| Isoniazid, B.P. |
|
176 | Sodium Folate........................ | Proven folic acid deficiency |
|
| Sprue or the sprue-like syndrome |
177 | (1) Sodium Fusidate.................... | With the written authority of the Director-General, |
| (2) Diethanolamine Fusidate | the treatment of serious staphylococcal infections in a patient where it is established by appropriate bacteriological testing that Sodium Fusidate or Diethanolamine Fusidate in combination with another antibiotic is an appropriate therapy |
178 | Soyalac............................ | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
179 | Spironolactone Tablets, B.P............... | With the written authority of the Director-General— |
|
| To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
180 | Stanolone........................... | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
181 | Stanozolol........................... | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on a long-term treatment with corticosteroids |
182 | Stilboestrol Diphosphate................. | Carcinoma of the prostate |
183 | Streptokinase......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
184 | Sulphasalazine........................ | Ulcerative colitis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
185 | (1) Surgical Cement.................... | Ileostomy or colostomy conditions |
| (2) Surgical Cement Solvent............... | For use with surgical appliances |
186 | (1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate | Eunuchoidism |
| Eunuchism | |
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) | |
| ||
| (2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate | Carcinoma of the breast |
| (3) Testosterone Implants, B.P. |
|
| (4) Testosterone Enanthate |
|
| (5) Testosterone Propionate Injection, B.P. |
|
187 | Tetanus Antitoxin, B.P. (Bovine) | Patients who have previously received an injection of equine serum |
188 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
189 | Thiethylperazine Maleate Tablets | Radiation sickness |
| and Suppositories | Nausea resulting from cytotoxic therapy |
190 | (1) Thioridazine....................... | Any disease or condition in a patient receiving |
| (2) Thioridazine Tablets, B.P. | treatment in or at an approved hospital Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Severe conduct disorders of children |
191 | Thyrotrophin......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
192 | Tragacanth, Indian (Gum Karaya) | Ileostomy or colostomy conditions |
193 | Tretamine........................... | Treatment in malignant neoplasia |
194 | Triacetyloleandomycin.................. | Amoebiasis |
|
| Brucellosis |
|
| Leptospirosis |
|
| Lymphogranuloma venereum |
|
| Pneumonia due to mycoplasma pneumoniae |
|
| Pneumonia, staphylococcal |
|
| Psittacosis |
|
| Rickettsioses |
|
| Staphylococcal septicaemia |
|
| Actinomycosis, trachoma, or any bacterial or spirochaetal infections where these cannot be safely and effectively treated by sulphonamides, phenoxymethylpenicillin or phenethicillin |
195 | Triamcinolone Acetonide Injection | With the written authority of the Director-General, treatment of keloids |
196 | (1) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Trifluoperazine Tablets, B.P. | Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
197 | Triglyde............................ | With the written authority of the Director-General, proven malabsorption |
198 | Trimethoprim with Sulphamethoxazole | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Respiratory tract infections or urinary tract infections where positive bacteriological evidence shows trimethoprim with sulphamethoxazole to be effective |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
199 | (1) Vinblastine Sulphate .. | Treatment in malignant neoplasia |
| (2) Vineristine Sulphate |
|
200 | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray | Ileostomy or colostomy conditions |
201 | (1) Viomycin Sulphate .. .. | Tuberculosis |
| (2) Viomycin Sulphate Injection, B.P. |
|
202 | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules | Any disease or condition in a pensioner |
Printed by Authority by the Government Printer of the Commonwealth of Australia